TIMOTHY NAUMANN: Open Payments
NPI 1992188379 · PIEDMONT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 101 payments from 17 companies in 2025. Trend: 2023 $4,291 · 2024 $5,044 · 2025 $2,596
Food & beverage: $1,663Travel & lodging: $933
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $1,216 |
| ABBVIE INC. | 31 | $334 |
| Vanda Pharmaceuticals Inc. | 12 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $151 |
| Almatica Pharma LLC | 9 | $139 |
| Alkermes, Inc. | 5 | $115 |
| Axsome Therapeutics, Inc. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Braeburn Inc. | 3 | $74 |
| Indivior Inc. | 3 | $66 |
Products named: SPRAVATO, VRAYLAR, REXULTI, HETLIOZ, LOREEV XR, Auvelity, CAPLYTA, BRIXADI.
Industry payments across SC — which companies pay providers there.
